Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Saturday, June 20, 2026Incyte Biosciences Japan GK today announced that Japans Ministry of Health Labour and Welfare MHLW has approved Minjuvi tafasitamab in combination with lenalidomide for the treatment of adults
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
Saturday, June 20, 2026The Ministry of Health Labour and Welfare in Japan has granted approval for Sarclisa isatuximab subcutaneous SC formulation in combination with approved standardofcare regimens for the treatment of multiple myeloma
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Friday, June 19, 2026Charles River Laboratories International Inc NYSE CRL announced a collaboration with Lilly TuneLab a collaborative AIML drug discovery platform created by Eli Lilly and Company Lilly
Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs
Friday, June 19, 2026Chai Discovery the AI company engineering models to discover new molecules today announced that certain Chai Discovery frontier AI model capabilities will be made available to companies participating in the Lilly TuneLab platform
Samsung Bioepis and Organon Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Friday, June 19, 2026Samsung Bioepis and Organon a global healthcare company with a deep expertise in biosimilars announced the expansion of their development and commercialization agreement whereby Organon will obtain commercialization
Bayer Completes Acquisition of Perfuse Therapeutics
Thursday, June 18, 2026Bayer today announced the completion of the acquisition of Perfuse Therapeutics Inc As a result Perfuse Therapeutics will now be fully integrated into Bayer As announced previously Bayer
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody
Thursday, June 18, 2026LabGenius Therapeutics LabGenius a drug discovery company combining machine learning ML and highthroughput experimentation to optimise therapeutic antibodies today announced a multiyear research collaboration
Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services
Thursday, June 18, 2026Oncotelic Therapeutics Inc Oncotelic or the Company OTCQB OTLC today announced the completion of key Phase objectives in its joint manufacturing automation initiative with TechForce Robotics Inc
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
Thursday, June 18, 2026Roche SIX RO ROP OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA for Lunsumio VELO
Cold Chain Technologies Launches CCT Rx Secure to Streamline Specialty Pharmacy Shipments
Thursday, June 18, 2026Cold Chain Technologies has launched CCT Rx Secure a new digital application designed to support specialty pharmacies in making more informed repeatable packout decisions for temperaturesensitive shipments
